• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Commun Dis Intell (2018) . Identifying a more severe emergent COVID-19 variant using Emergency Departments' routinely collected clinical measures

tetano

Editor, Senior Moderator
Commun Dis Intell (2018)


. 2023 Mar 23;47.
doi: 10.33321/cdi.2023.47.16.
Identifying a more severe emergent COVID-19 variant using Emergency Departments' routinely collected clinical measures


Adelaide Nyinawingeri[SUP] 1 [/SUP], Michael Staff[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: To determine whether a clinical scoring system (the mPRIEST score) could be used to identify an emerging coronavirus disease 2019 (COVID-19) variant with increased clinical severity.
Design: Cross sectional study comparing two time periods (Delta and Omicron waves).
Setting: Public Emergency Departments in Northern Sydney Local Health District.
Participants: Patients presenting during August 2021 (Delta wave) and January 2022 (Omicron wave) with confirmed COVID-19. Data on age, gender, temperature, heart rate, systolic blood pressure, respiratory rate, oxygen saturation and mental status were extracted from patients' electronic medical records to assess clinical disease severity at presentation.
Main outcome measures: Modified Pandemic Respiratory Infection Emergency System Triage (mPRIEST) score calculated using routinely collected data.
Results: A sample of 262 records of COVID-19 positive patients presenting during the Delta and initial Omicron waves were reviewed with 205 having COVID-19 as their primary diagnosis. During the Delta wave 48.1% had scores above 4 compared to 35.1% for the Omicron wave (p = 0.03). The median score was also significantly higher for the Delta group (4 vs 3; p = 0.01). Hospitalisations, admissions to ICU and deaths during admission were higher among patients presenting during the Delta wave than among those presenting during the Omicron wave.
Conclusion: The mPRIEST score was significantly higher for patients for whom the predominant circulating variant was Delta than those for whom the predominant circulating variant was Omicron. This finding is consistent with international reporting of severity measured by hospital admission data and demonstrates the score's possible ability to identify an emergent strain with higher morbidity and mortality.

Keywords: COVID-19; COVID-19 variants; emergency departments; mPRIEST score.
 
Back
Top Bottom